about
Hypoxic regulation of erythropoiesis and iron metabolismInference for Stochastic Chemical Kinetics Using Moment Equations and System Size ExpansionHepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in ratsIsocitrate ameliorates anemia by suppressing the erythroid iron restriction response.A retrospective study of 180 anaemic cats: features, aetiologies and survival data.Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.Nonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report.[Preoperative anemia in orthopedic surgery: clinical impact, diagnostics and treatment].Overview of supportive care in patients receiving chemotherapy: antiemetics, pain management, anemia, and neutropenia.A link between premenopausal iron deficiency and breast cancer malignancyThe role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational studyClinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia.Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shockMouse models of anemia of cancerEnhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli geneOral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism.The colony-stimulating factors and cancer.Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins.Iron deficient erythropoiesis might play key role in development of anemia in cancer patients.Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W).Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial.Enhanced eryptosis contributes to anemia in lung cancer patientsRegulation of erythropoiesis by hypoxia-inducible factorsRed blood cell transfusion triggers in acute leukemia: a randomized pilot studyErythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.Supportive care in hemato-oncology: a review in light of the latest guidelines.Red blood cells from pluripotent stem cells for use in transfusion.Erythropoiesis-stimulating agents for anemic patients with cancer.Management of anemia in cancer patients.Organ-protective and immunomodulatory effects of erythropoietin--an update on recent clinical trials.Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.Activin receptor antagonists for cancer-related anemia and bone disease.Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation.Erythropoietin and co.: intrinsic structure and functional disorder.Neonatal neuroblastoma with adrenal primary and metastasis to the liver: A case report and a review of literaturePolyphyllin D induces apoptosis in human erythrocytes through Ca²⁺ rise and membrane permeabilization.Quantitative detection of eryptosis in human erythrocytes using tunable resistive pulse sensing and annexin-V-beads.The problem of anaemia in patients with colorectal cancer.Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women.
P2860
Q24609166-3E0755FB-03AC-40BF-A90D-D2123E60CD26Q28552862-E81F954C-E399-475E-B5F7-E72D49612D52Q28568757-C00BB2AB-51F6-4C87-A731-83AFA6181A31Q30418035-8A6FD942-487A-4885-9D53-EF9D524E5D86Q30567923-87E6BC02-10EB-45BA-B42B-4F499DEA83BCQ31056773-1B95AD0F-9232-4500-B783-B941E5C2B33EQ33885900-43C85E8A-FB81-4E04-B7E0-1D1B36BCC443Q34020541-7D927B2F-2B65-44DC-A6F5-7DB630B56E73Q34635638-77408722-5ECD-4DD5-999A-6F0388A7C6F9Q34783846-40B20F77-8A74-4AA6-B0C9-C79E3F979785Q34798132-BC8A7026-7F92-4DC6-9ECB-74E94B92A7E7Q35114910-F333BED1-55E0-4BAE-B930-D49DB82C16ECQ35119905-44EA9BBC-035F-43B9-9907-DE8A25EDD3B2Q35135015-4E8985AD-F83F-42DE-90EE-5170BCC43CC2Q35195018-7952D1B3-D143-4CA4-8767-C3AAA9E4EE20Q35787122-09D962C1-D5A8-44F7-AAF6-16A84F223DD8Q35936937-77C620CF-C989-439C-85EC-FEA462D78E51Q36603518-902E1EF1-1504-4447-A297-14933CBE2BA1Q36619022-07ADF120-D23E-4C23-9C70-A7E98139A896Q36776653-5657DB46-2018-4A94-924E-212CB955359EQ36862486-D966C6FE-2453-4E91-84D8-FCC3B7ED87C5Q36976986-2262B1DA-1C62-42F6-8AE8-6AAC81D938B9Q37046509-79606104-48B2-4E8E-8C54-84F044EF5B78Q37063716-3EA6E992-243A-43AB-A87D-C96B5DD775FDQ37178943-611FA3B8-3996-42E2-BC84-EB456F04DBD9Q37689196-1BC8EFCF-18C7-4542-9246-8E6E51B8489CQ37702827-00F11CA1-3177-4707-94E6-A2414A9657B0Q37747344-F95750E1-84CD-4595-B887-5FB5684ABC4AQ37810966-2F9E4A47-6FF1-4FF2-9BE9-0CAFB8B1A612Q37861195-EBB12910-DFDA-4C9E-AA9A-D76F2994EEE6Q37946499-65D2FD56-62B7-4D4A-A70E-842540E1B1C2Q37982120-1A62F5FE-FD42-4A73-B164-BF52FB01469EQ38057813-1807A2E5-4C24-4B4A-83DE-A36A6E5F4AEEQ38260255-D2CE2A36-C6AC-4E6B-B0DA-97708DFF2382Q39005050-5FD9FC59-C775-48D0-8516-6B8FFF35F956Q39066905-75321794-FAF6-4A86-BE07-65B6567AAC6EQ39393804-A1C918E6-5512-4BFE-B0E5-C390220DACBDQ41600943-5B86E61C-B6C6-4C26-9DD4-D579B6ABD6CCQ42416148-B13E2192-1B85-4BB7-9E5D-FCE1206BA8FAQ45412595-03F217A3-0CB1-4A5B-B7F5-D16D51650655
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anemia management in oncology and hematology.
@en
Anemia management in oncology and hematology.
@nl
type
label
Anemia management in oncology and hematology.
@en
Anemia management in oncology and hematology.
@nl
prefLabel
Anemia management in oncology and hematology.
@en
Anemia management in oncology and hematology.
@nl
P2093
P1433
P1476
Anemia management in oncology and hematology.
@en
P2093
Heinz Ludwig
Jerry L Spivak
Pere Gascón
P356
10.1634/THEONCOLOGIST.2009-S1-43
P478
14 Suppl 1
P577
2009-01-01T00:00:00Z